Dutch health insurer Zilveren Kruis partners with eye care startup

easee's online eye test is the world's first CE certified online eye test.
By Sara Mageit
10:28 am

Netherlands’ largest health insurer, Zilveren Kruis and the Dutch vision care startup, easee are entering into a partnership for the implementation of easee’s CE certified online eye test.


Agreements have now been made with employers in the energy sector and financial industry. Vision problems often occur in these sectors and can lead to absenteeism, reduced productivity and work safety issues.

Employees who are insured through these employers are reimbursed for an online test from their supplementary insurance.

easee developed their proprietary platform in line with the requirements of the European Commission. Research proving easee’s online refraction test is as accurate as an in person exam was published in the Journal of Medical Internet Research.


In October 2020, retail company CVS launched a telemedicine service which lets patients take a digital eye exam and get their prescription renewed by a doctor.

NovaSight raised $8 million in Series A funding to tackle vision disorders worldwide, by advancing research for eye treatment devices and assisting in the development of future eye care products for myopia control.


Jan-Willem Evers, director of Zilveren Kruis: “In the energy sector and the financial sector, visibility problems have a significant impact on labor productivity. We offer this accessible solution to make policyholders feel better in their working environment.”

Yves Prevoo, CEO of easee: “Research shows that the impact of uncorrected refractive errors can reduce performance on the work floor by up to 20% due to vision problems. We are delighted that the largest health insurer in the Netherlands wants to tackle this problem with us and offers reimbursement for it. Our mission is to make clear vision easily accessible to everyone. This proves that we are on the right track."


The latest news in digital health delivered daily to your inbox.

Thank you for subscribing!
Error! Something went wrong!